Cost-effectiveness of interferon-alpha as maintenance therapy in chronic myelogenous leukemia.
Messori
A
A
Becagli
P
P
Trippoli
S
S
D000970:Antineoplastic Agents / Q000191:economics* / Q000627:therapeutic use*; D003362:Cost-Benefit Analysis; D006801:Humans; D016898:Interferon-alpha / Q000191:economics* / Q000627:therapeutic use*; D015464:Leukemia, Myelogenous, Chronic, BCR-ABL Positive / Q000188:drug therapy*
D000970:Antineoplastic Agents; D016898:Interferon-alpha